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AGGLUTINATION  PHENOMENA  IN  LOBAR 
PNEUMONIA.* 
BY  HENRY  T.  CHICKERING,  M.D. 
(From the Hospital  of  The Rockefeller Institute for Medical Research.) 
Numerous investigators (I to I I) have noted that when pneumococci are grown 
in immune serum the organisms exhibit unusual  characterisC~ics,  Certain observ- 
ers have also shown that the sera of animals immunized to pneumococci are able 
to cause agglutination of these organisms  when the  ordinary  agglutination tech- 
nique is employed. 
In  19oo Besan~on and  Griffon  (12)  noted the presence of agglutinins in the 
blood  of  patients  ill  of  and  convalescent  from  lobar  pneumonia.  They  found 
that often the homologous strain  (,the strain derived from the patient)  was agglu- 
tinated  when  a  heterologous strain  was  not.  This  fact  suggested  that  the  vari- 
ous  strains  of pneumococci might possess biological differences which  could not 
be detected by ordinary cultural  methods.  Eyre and  Washbourn  (I3)  and  Gar- 
g~.no and Fattori  (14)  also noted such differences, bu~ Neufeld and H~indel  (I5) 
were the first to study thoroughly immunological variations in pneumococci.  They 
worked,  however, with  relatively few strains  of pneumococci. 
Dochez  (i6)  and Dochez and  Gillespie (I7), working with a large number  of 
strains  of pneumococci, isolated  from  patients  suffering  from  lobar  pneumonia, 
were able  to  differentiate pneu,mococci into  four groups  on  the  basis  of cultural 
and  immunological  reactions.  The  three  main  groups  were  distinguishable  by 
agglutination  and  animal  protection  experiments  with  a  fourth  group  which 
includes all strains  of pneumococci which cannot be otherwise classified. 
More  recently  Lister  (I8)  in  South  Africa,  approaching  the  problem  from 
another standpoint,  has differentiated into four groups  eighteen of twenty strains 
of pneumococci isolated by puncture  of the lungs  of patients  having lobar pneu- 
monia.  This he was able to do by cross agglutination tests with cultures of these 
strains of pneumococci and the sera derived from these patients at about the time 
of crisis.  Two  strains  he  found  to  be  non-agglutinable. 
The present study has  been carried out with the purpose of de- 
termining the time of appearance and disappearance of agglutinins 
in the blood of patients suffering from pneumonia, and of learning 
more concerning the  specific  character  of  these  agglutinins,  espe- 
cially their specific  relation to the various  groups  of pneumococci. 
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METI{ODS. 
Neufeld  (I9),  Jehte  (20),  Kindborg  (2I),  and  others  have 
found that pneumococci are agglutinated by the serum of immunized 
animals  when this  is diluted to  I  to 60 or even  I  to.Ioo,ooo  (2I), 
and  that  the  serum  of patients  diluted even to  I  to  16o may cause 
such agglutination when the homologous strains are used.  We have 
found, however, that  the reaction  is highly specific even as  regards 
the various groups of organisms, so that  for the purpose in view the 
use  of  diluted  serum  seemed  unnecessary.  This  is  especially  true 
since  normal  human  blood  does  not  contain  agglutinins  for  the 
pneumococcus,  and  spontaneous agglutination  of pneumococci  does 
not occur with  the method employed.  Therefore,  in  making  these 
tests  equal parts  (0.3  of a  cubic centimeter)  of  a  broth  culture  of 
the  organism  to  be  tested  and  of  the  patient's  serum  were  mixed 
together  and  macroscopic  readings  were  made  after  two  hours  in 
a  water bath at 37 °  C.  and  after twenty-four hours  in  the  ice-box. 
In  practically  every case  agglutination  was  apparent  at  the  end  of 
the two hour  period,  if  it occurred at all. 
The  cultures  of  pneumococci  were obtained  from  culture  of  the 
heart's  blood  of  a  mouse  inoculated  intraperitoneally  with  the 
patient's  washed  sputum,  or  from  direct  blood  culture,  or  from 
culture of material  obtained by puncture  of the tung of the patient. 
Certain  observers  (22)  have  noted  that  cultures  fresh  from  the 
human  host  are  occasionally not  agglutinable.  Therefore,  all  cul- 
tures were grown for several generations on artificial culture media. 
To  make  sure  that  the  cultures  employed  were  agglutinable,  they 
were all  tested  with  antipneumococcus  serum  specific  for  groups  I 
and II, before they were used for the agglutination tests with human 
serum.  At each examination the patient's serum was tested against 
the homologous organism  and also against  stock cultures belonging 
to groups  I  and II. 
The  blood to be tested  was drawn  aseptically  from  an  arm  vein 
of  the  pat{ent.  It  was  allowed  to  clot,  was  centrifuged,  and  the 
clear serum was pipetted off.  The  tests were made  with  serum  as 
fresh as  possible,  for it  has  been  found that  agglutinins  in  human 
blood disappear  quickly after  it  is  stored.  This  is  especially so  if 
the  serum  has  not been separated  from  the  clot.  With highly  ira- Henry  T.  Chickering.  601 
mune horse serum this  is  not the case.  Serum two years old  has 
been found still  to possess  strong agglutinative properties. 
The correlation between the clinical severity of lobar pneumonia 
and the bacteriological findings has not only prognostic importance, 
but  also  considerable bearing on  the effects of serum therapy.  It 
has been learned that infections which are included in groups I  and 
II  are  usually severe.  The  serum  treatment  of  lobar  pneumonia 
has been more successful in  the cases  included in  group  I  than  in 
group  II,  and  experimentally it  has  been  found  that  antipneurno- 
coccus serum I  (a  serum produced by highly immunizing a  horse 
to  pneumococci belonging to group  I)  possesses  greater protective 
and curative properties than a  serum similarly produced by organ- 
isms included in group II.  It will be noted in the protocol that six 
of  the  fatal  cases  were  group  II  infections,  some  of  which were 
thoroughly treated with serum. 
On  the  other  hand,  infections  due  to  organisms  in  the hetero- 
geneous group  (group  IV)  are almost always mild  and the prog- 
nosis  is  favorabIe.  Infections  due  to  Pneumococcus  mucosus 
(group III)  are often severe, but as this organism under ordinary 
cultural methods is non-agglutinable, this group may be left out of 
consideration for the present. 
Bearing in mind these apparent differences in the type of disease 
produced by the different groups of pneumococci, we may make an 
analysis  of  the  results  of  the  agglutination  reactions. 
DISCUSSION. 
The  protocol  of  all  the  cases  studied  is  briefly summarized  in 
table I. 
TABLE  I. 
Group. 
I  ..................  16 
II  .................  .  I3 
III  (mucosus)  ........  ~ 
IV (heterologous) .....  9 
NO, of Cases.  Agglutinlns preselat at  I  Neverpresent. 
some  timein the disease. 
o 
6 
2 
4 
Per ce~t.  pres- 
ent. 
IO0 
53.8 
0 
55.5 
In all, sera from forty cases of lobar pneumonia, due to different 
types of pneumococcus, were examined.  The sera of all the sixteen 602  Agglutination  Phenomena  in  Lobar  Pneumonia. 
cases  belonging  to  group  I  showed  the  presence  of  agglutinins  at 
some  stage  of  the  disease.  Six  of  the  thirteen  cases  in  group  II 
showed no agglutinins.  In  five of these negative  cases the  disease 
terminated  fatally.  Repeated examinations  of the sera of these pa- 
tients  showed  no  agglutinins  for  their  own  organism  or  for  stock 
cultures  I  and  II.  In  all  these cases there  was no  doubt as  to  the 
type  of  the  infecting  pneumococcus,  for  four  had  positive  blood 
cultures and  from the fifth an organism  belonging to group II  was 
recovered  by  lung  puncture.  This  confirms  the  observations  of 
Lister, who was unable to demonstrate the presence of agglutinins  in 
the  sera  of  four  cases  that  terminated  fatally. 
The impression has been gained  that  the non-development  of ag- 
glutinins  in  the  sera  of patients  with  severe infections  is  evidence 
of  grave  prognostic  import.  Exceptions  to  this  observation  have 
been  noted,  however,  in  which  a  feeble  agglutination  reaction  de- 
veloped late in two fatal cases.  In one of these the patient's  serum 
showed agglutinins  on the thirteenth  day  (the day of admission  to 
the  hospital),  the  patient  dying  of  a  complicating  meningitis  and 
empyema on  the  seventeenth  day.  This  case  had  no serum  treat- 
ment.  In the second case, which was treated with antipneumococcus 
serum,  agglutinins  were demonstrable  on the  thirteenth  day of the 
disease.  This  patient  had  four lobes involved and  died in  extreme 
dyspnea on the  following day. 
Observations  were  made  on  only  two  patients  infected  with 
Pneumococcus mucosus.  Hanes  (23)  has shown that  members  of 
this  group  are  specifically  agglutinable  when  treated  according  to 
the method of Porges  (24),  but that  they do not agglutinate  when 
subjected  to  the  usual  agglutination  method.  Since  the  latter 
method  was  employed  in  the  present  investigation,  no  agglutinins 
were demonstrable  in the  cases recorded. 
In  four of the  nine  cases belonging to group  IV,  no agglutinins 
were noted in the patients'  sera.  Two of these negative cases were 
mild in type, one was quite ill,  having  a  posi'tive blood culture,  and 
the  fourth  was  complicated  with  influenza.  From  this  last  case 
large numbers of Bacillus influenzce were recovered from the sputum. 
Unfortunately a  lung puncture yielded no culture.  It is  impossible 
to say absolutely whether Bacillus influen~ce  or an atypical pneumo- Henry  T.  Chickering.  603 
coccus  or both were the etiological factors.  In four of the five cases 
showing agglutination of the homologous organism, the reaction was 
feeble and lasted only one day, and in one case, which presented a 
very severe clinical picture, with positive blood cultures and spreading 
lesions,  the  serum  developed strong  agglutinative  power  for  the 
patient's own organism on the day of the crisis  (ninth day), which 
power persisted for eighty-four days.  This patient later developed 
an abscess of the opposite lung and resolution of the original lesion 
was very slow.  As the agglutinative power of this patient's serum 
wa  s  s o  strong and persistent, a  few attempts were made to agglu- 
tinate with this serum other strains of organisms belonging to group 
IV, but all with negative results.  It has seemed that in this  case, 
as  in  two  others  in  which agglutinins  were  demonstrated over  a 
period  of  I I 7  days  and  I I2  days  respectively,  the  duration  of 
the lesion (delayed resolution)  had some relation to the persistence 
of agglutinins in the blood.  In the other twenty-five cases showing 
positive agglutination at  one time or another, the duration of this 
phenomenon was relatively short; the longest was twenty-one days, 
the average about seven days. 
These findings are not wholly in accordance with the results of 
Jehle's investigations, who found that the sera of only a smaU num- 
ber  of  patients  agglutinated  the  pneumococcus  forty-eight  hours 
after the crisis and none after four days. 
Agglutinins  develop  usually  just  before,  at,  or  just  af.ter  the 
crisis (table II, pp. 6o7-I3).  During this critical period of the dis- 
ease Dochez (25)  also demonstrated the presence of protective sub- 
stances in human serum.  Only two patients showed agglutinative 
power any appreciable time before  the crisis;  one showed it three 
days before, the second two days before the crisis.  The former re- 
ceived antipneumococcus serum, the latter did not. 
Too  few cases  have been studied to  draw conclusions as to the 
effect of serum treatment on the appearance of  agglutinins in the 
patients'  blood.  Of  the  sixteen  patients  in  group  I,  agglutinins 
appeared in the serum of all.  Eleven of these patients were treated 
with serum, and five received no serum.  Of the thirteen cases  in 
group II, agglutinins were demonstrable in the sera of seven eases, 
and in six cases no agglutinins could be demonstrated at any time. 604  Agglutination  Phenomcna  in  Lobar  Pneumonia. 
Eight  of the  thirteen  cases  in  this  group  were treated  with  serum, 
and  of  these  three  developed  agglutinins  and  five  did  not.  On 
the other hand,  four patients  showed agglutinins  in the blood with- 
out serum treatment  and none were demonstrated  in one  fatal case. 
Thus  it  would  seem  that  serum  treatment  had  but  little  influence 
on the development of agglutinins. 
Probably  the  determination  of  the  presence  of  agglutinins  will 
have  little  practical  bearing  on  the  diagnosis  and  treatment  of  the 
disease.  However,  the  fact  tha't  an  organism  derived  from  the 
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The  relative  time  of  development  of  agglutinins  for  homo- 
organisms  in  a  case  of  lobar  pneumonia.  I-----stock  culture 
belonging to group I.  II ~  stock culture  of  pneumococcus  be- 
longing  to  group  II.  H  =  homologous  cul.ture  of  pneumococ.cus,  i.  e.,  that  de- 
rived  from  the patient. 
sputum  is  agglt/tinated  by the  patient's  serum  is  corroborative  evi- 
dence  that  this  organism  is  the  etiological  agent  concerned.  In 
practically every case observed, in  case the serum agglutinated  any 
organism,  it  caused  agglutination  of  the  organism  obtained  from 
culture  of  the heart's  blood of  a  mouse injected  with  the  patient's 
washed sputum.  Agglutination  is  of no  help in  the early  recogni- Henry  T,  Chickering.  605 
tion of the type of organism concerned, inasmuch as the appearance 
of agglutinins occurs relatively late in the disease. 
In several instances it has been  found that the first organism to 
be agglutinated was  the homologous strain  and only later  was the 
stock strain  agglutinated.  This  illustrates  the  great  specificity  of 
the  reaction even  when no  dilutions  are  used.  Clough  (26)  has 
noted  this  marked  specificity of  the  serum of patients  recovering 
from lobar pneumonia in his experiments, demonstrating the power 
of  such  sera  to  render  virulent  pneumococci phagocytable.  One 
case on which observations were made at  frequent intervals  shows 
this group specificity clearly (text-figure I). 
CONCLUSIONS. 
I.  Agglutinins are present in the blood of patients suffering from 
lobar  pneumonia during some stage  of  the  disease in a  large  per- 
~:entage  (73.8 per cent.)  of the cases due to pneumococci belonging 
in groups I,  II, and IV. 
2.  In most very severe and fatal cases agglutinins cannot be dem- 
onstrated, and it is probable that their absence during the later days 
of the disease may have unfavorable prognostic significance. 
3-  No  agglutinins  are  demonstrable by  the  technique  employed 
in the blood of patients suffering from infection with Pneumococcus 
mucosus  (group III). 
4.  In  certain  cases  agglutinins  may  be  demonstrable  for  only 
one day, and in Other cases they may persist for several weeks. 
5.  When  agglutinins  are  demonstrable  they  usually  appear  at 
about the time of the crisis. 
6.  It  has  not  been possible  to  demonstrate that  treatment  with 
immune serum has any effect on the appearance of agglutinins. 
7-  The agglutinins present in cases  due to  organisms of types  I 
and  II  are  always  specific  for  the  type  of  organism  causing  the 
infection.  In certain cases the agglutination reaction may be more 
active or appear earlier when the homologous organism is employed 
than when other organisms of the group are  used  in the test.  In 
cases due to organisms of type IV, the serum never causes agglutina- 
tion of any  organism except the  homologous one. 606  Agglutination  Phenomena  in  Lobar  Pneumonia. 
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